Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | ATP binding cassette sub family B | 0.0014 | 0.6117 | 0.6117 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0014 | 0.6347 | 0.6347 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.9771 | 0.9737 |
Giardia lamblia | ABC transporter, putative | 0.0018 | 1 | 1 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0014 | 0.6347 | 0.6347 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0014 | 0.6347 | 0.6347 |
Schistosoma mansoni | multidrug resistance protein | 0.0018 | 1 | 1 |
Echinococcus granulosus | 5'partial|ATP binding cassette sub family B | 0.0014 | 0.6117 | 0.6117 |
Brugia malayi | multidrug resistance related protein 1 | 0.0018 | 1 | 1 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0014 | 0.6347 | 0.6347 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0014 | 0.6347 | 0.6347 |
Trypanosoma brucei | p-glycoprotein | 0.0018 | 1 | 1 |
Brugia malayi | ABC transporter family protein | 0.0014 | 0.6347 | 0.2961 |
Schistosoma mansoni | multidrug resistance protein | 0.0018 | 1 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0013 | 0.481 | 0.4046 |
Trypanosoma brucei | multidrug resistance protein E | 0.0018 | 1 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.6347 | 1 |
Trypanosoma cruzi | multidrug resistance-associated protein, putative | 0.0018 | 1 | 1 |
Trichomonas vaginalis | taga, putative | 0.0014 | 0.6347 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0018 | 1 | 1 |
Trichomonas vaginalis | ABC transporter, putative | 0.0014 | 0.6347 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.6347 | 1 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0014 | 0.6347 | 0.6347 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.6347 | 0.5809 |
Schistosoma mansoni | multidrug resistance protein | 0.0018 | 1 | 1 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0014 | 0.6347 | 1 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0014 | 0.6347 | 0.6347 |
Leishmania major | p-glycoprotein | 0.0014 | 0.6347 | 0.2961 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.6347 | 1 |
Giardia lamblia | MRP-like ABC transporter | 0.0018 | 1 | 1 |
Trichomonas vaginalis | ABC transporter, putative | 0.0014 | 0.6347 | 1 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.0014 | 0.6347 | 1 |
Trichomonas vaginalis | abcb9, putative | 0.0014 | 0.6347 | 1 |
Echinococcus granulosus | multidrug resistance associated protein 7 | 0.0018 | 1 | 1 |
Trichomonas vaginalis | abcb9, putative | 0.0014 | 0.6347 | 1 |
Leishmania major | ATP-binding cassette protein subfamily C, member 2, putative | 0.0018 | 1 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0013 | 0.481 | 0.4046 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0014 | 0.6347 | 0.6347 |
Brugia malayi | multidrug resistance protein 3 | 0.0014 | 0.6347 | 0.2961 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0013 | 0.481 | 0.2107 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 1 | 1 |
Leishmania major | pentamidine resistance protein 1 | 0.0018 | 1 | 1 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0014 | 0.6347 | 0.6347 |
Loa Loa (eye worm) | ATP-binding cassette sub-family B member 2 | 0.0014 | 0.6347 | 0.5809 |
Onchocerca volvulus | 0.0014 | 0.6347 | 0.5 | |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.6347 | 1 |
Trichomonas vaginalis | ABC transporter, putative | 0.0014 | 0.6347 | 1 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0014 | 0.6347 | 0.6347 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.6347 | 1 |
Echinococcus multilocularis | multidrug resistance associated protein 7 | 0.0018 | 1 | 1 |
Chlamydia trachomatis | ABC transporter ATP binding protein/permease | 0.0014 | 0.6347 | 0.5 |
Plasmodium falciparum | multidrug resistance protein 1 | 0.0014 | 0.6347 | 0.5 |
Leishmania major | ATP-binding cassette protein subfamily C, member 1, putative | 0.0018 | 1 | 1 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0014 | 0.6347 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 1 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.6347 | 1 |
Echinococcus granulosus | multidrug resistance associated protein 1 | 0.0018 | 1 | 1 |
Trypanosoma brucei | multidrug resistance-associated protein, putative | 0.0018 | 1 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.6347 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.6347 | 1 |
Entamoeba histolytica | ATP-binding cassette protein, putative | 0.0018 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.6117 | 0.5546 |
Giardia lamblia | Multidrug resistance-associated protein 1 | 0.0018 | 1 | 1 |
Schistosoma mansoni | multidrug resistance protein | 0.0018 | 1 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.6347 | 1 |
Trypanosoma cruzi | multidrug resistance-associated protein, putative | 0.0018 | 1 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.6347 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.6347 | 1 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0014 | 0.6347 | 0.6347 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0014 | 0.6347 | 1 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0014 | 0.6347 | 0.6347 |
Trypanosoma cruzi | multidrug resistance protein E, putative | 0.0018 | 1 | 1 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0014 | 0.6347 | 1 |
Entamoeba histolytica | ATP-binding cassette protein, putative | 0.0018 | 1 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.6347 | 1 |
Loa Loa (eye worm) | multidrug resistance-associated protein | 0.0011 | 0.3653 | 0.272 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.0013 | 0.481 | 0.5 |
Entamoeba histolytica | ABC transporter, putative | 0.0018 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.6347 | 0.5809 |
Leishmania major | ATP-binding cassette protein subfamily B, member 2, putative | 0.0014 | 0.6347 | 0.2961 |
Loa Loa (eye worm) | multidrug resistance protein 3 | 0.0014 | 0.6347 | 0.5809 |
Plasmodium vivax | multidrug resistance protein 1, putative | 0.0014 | 0.6347 | 0.5 |
Echinococcus multilocularis | multidrug resistance associated protein 4 | 0.0011 | 0.3424 | 0.3424 |
Entamoeba histolytica | ATP-binding cassette protein, putative | 0.0018 | 1 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.6347 | 1 |
Giardia lamblia | Multidrug resistance-associated protein 1 | 0.0018 | 1 | 1 |
Trypanosoma brucei | multidrug resistance-associated protein, putative | 0.0018 | 1 | 1 |
Leishmania major | ATP-binding cassette protein subfamily C, member 6, putative | 0.0018 | 1 | 1 |
Echinococcus multilocularis | multidrug resistance associated protein 1 | 0.0018 | 1 | 1 |
Leishmania major | ABC-thiol transporter | 0.0018 | 1 | 1 |
Entamoeba histolytica | ATP-binding cassette protein, putative | 0.0018 | 1 | 1 |
Mycobacterium tuberculosis | Probable transmembrane multidrug efflux pump | 0.0014 | 0.6347 | 0.5 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0014 | 0.6347 | 0.6347 |
Leishmania major | ATP-binding cassette protein subfamily C, member 5, putative | 0.0018 | 1 | 1 |
Trichomonas vaginalis | ABC transporter, putative | 0.0014 | 0.6347 | 1 |
Echinococcus granulosus | multidrug resistance associated protein 4 | 0.0011 | 0.3424 | 0.3424 |
Toxoplasma gondii | ABC transporter transmembrane region domain-containing protein | 0.0018 | 1 | 1 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0014 | 0.6347 | 1 |
Trichomonas vaginalis | abcb9, putative | 0.0014 | 0.6347 | 1 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.0014 | 0.6347 | 1 |
Loa Loa (eye worm) | ABC transporter transmembrane region family protein | 0.0018 | 1 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.6347 | 1 |
Loa Loa (eye worm) | CYP4Cod1 | 0.0013 | 0.481 | 0.4046 |
Leishmania major | p-glycoprotein e | 0.0018 | 1 | 1 |
Entamoeba histolytica | multidrug resistance protein, putative | 0.0018 | 1 | 1 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0014 | 0.6347 | 0.6347 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.6347 | 1 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0013 | 0.481 | 0.2107 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | > 25 uM | Inhibition of anchorage independent growth of H-Ras(61L)-transformed NIH3T3 fibroblasts in soft agar | ChEMBL. | 10508429 |
IC50 (functional) | > 25 uM | Inhibition of anchorage independent growth of H-Ras(61L)CVLL-transformed NIH3T3 fibroblasts in soft agar | ChEMBL. | 10508429 |
IC50 (functional) | > 25 uM | Inhibition of anchorage independent growth of H-Ras(61L)-transformed NIH3T3 fibroblasts in soft agar | ChEMBL. | 10508429 |
IC50 (functional) | > 25 uM | Inhibition of anchorage independent growth of H-Ras(61L)CVLL-transformed NIH3T3 fibroblasts in soft agar | ChEMBL. | 10508429 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.